China Oncology ›› 2022, Vol. 32 ›› Issue (7): 635-642.doi: 10.19401/j.cnki.1007-3639.2022.07.007

• Review • Previous Articles     Next Articles

Application progress of single-cell sequencing technology in breast cancer research

LIU Qiang()(), FANG Yi, WANG Jing()()   

  1. Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2021-12-01 Online:2022-07-30 Published:2022-08-09
  • Contact: WANG Jing E-mail:liuqaing@email.ncu.edu.cn;wangjing@cicams.ac.cn

Abstract:

Breast cancer is a malignant tumor with the highest incidence in women in the world, and it represents the leading cause of cancer-related deaths in women. Breast cancer is a highly heterogeneous disease, including the heterogeneity between tumors and even within the tumor microenvironment, making precise classification and treatment of the disease difficult. The application of traditional high-throughput sequencing technology in breast cancer research has provided an important reference for revealing the occurrence and development of breast cancer, driving genes, precise classification, diagnosis and treatment. However, the limitation of traditional high-throughput sequencing technology is its inability to explore heterogeneity within the tumor microenvironment. The single-cell sequencing technology emerged in recent years has been greatly improved in terms of sensitivity, accuracy and efficiency, enabling us to analyze single-cell genome information in complex mixed cells, which has shown great performance in studying tumor heterogeneity. In recent years, there are a number of important research results obtained by harnessing single-cell sequencing technology in breast cancer research, including analyzing breast cancer transcriptome at the single-cell level, exploring the heterogeneity of breast cancer microenvironment, breast cancer drug resistance mechanisms, the clonal heterogeneity and clonal evolution of breast cancer, and comprehensively mining single-cell public data resources to reveal the heterogeneity of breast cancer. This article reviewed important research in recent years regarding the application of single-cell sequencing technology in breast cancer era. We aimed to provide references for breast cancer researchers to manipulate the single-cell sequencing technology and promote the in-depth use of single-cell sequencing technology in breast cancer research.

Key words: Breast cancer, Single-cell sequencing, Heterogeneity, Tumor microenvironment

CLC Number: